9,10-phenanthrenequinone has been researched along with Lung Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakaki, M; El-Kabbani, O; Endo, S; Hara, A; Hosogai, M; Matsunaga, T | 1 |
1 other study(ies) available for 9,10-phenanthrenequinone and Lung Diseases
Article | Year |
---|---|
9,10-phenanthrenequinone induces monocytic differentiation of U937 cells through regulating expression of aldo-keto reductase 1C3.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Apoptosis; Carcinogens; Caspases; CD11b Antigen; CD18 Antigens; Cell Differentiation; Humans; Hydroxyprostaglandin Dehydrogenases; Inhalation Exposure; Lung Diseases; Monocytes; Mutagens; ortho-Aminobenzoates; Phenanthrenes; Reactive Oxygen Species; Signal Transduction; Tetradecanoylphorbol Acetate; U937 Cells; Vehicle Emissions | 2012 |